178 related articles for article (PubMed ID: 10353828)
21. Phenylalanine 30 plays an important role in receptor binding of verotoxin-1.
Clark C; Bast D; Sharp AM; St Hilaire PM; Agha R; Stein PE; Toone EJ; Read RJ; Brunton JL
Mol Microbiol; 1996 Feb; 19(4):891-9. PubMed ID: 8820657
[TBL] [Abstract][Full Text] [Related]
22. Glycolipid receptors for verotoxin and Helicobacter pylori: role in pathology.
Lingwood CA
Biochim Biophys Acta; 1999 Oct; 1455(2-3):375-86. PubMed ID: 10571026
[TBL] [Abstract][Full Text] [Related]
23. Alteration of the glycolipid binding specificity of the pig edema toxin from globotetraosyl to globotriaosyl ceramide alters in vivo tissue targetting and results in a verotoxin 1-like disease in pigs.
Boyd B; Tyrrell G; Maloney M; Gyles C; Brunton J; Lingwood C
J Exp Med; 1993 Jun; 177(6):1745-53. PubMed ID: 8496689
[TBL] [Abstract][Full Text] [Related]
24. Apoptosis induced in Burkitt's lymphoma cells via Gb3/CD77, a glycolipid antigen.
Mangeney M; Lingwood CA; Taga S; Caillou B; Tursz T; Wiels J
Cancer Res; 1993 Nov; 53(21):5314-9. PubMed ID: 8221667
[TBL] [Abstract][Full Text] [Related]
25. A novel pentamer versus pentamer approach to generating neutralizers of verotoxin 1.
Stone E; Hirama T; Chen W; Soltyk AL; Brunton J; MacKenzie CR; Zhang J
Mol Immunol; 2007 Mar; 44(9):2487-91. PubMed ID: 17134756
[TBL] [Abstract][Full Text] [Related]
26. Polyisobutylmethacrylate modifies glycolipid binding specificity of verotoxin 1 in thin-layer chromatogram overlay procedures.
Yiu SC; Lingwood CA
Anal Biochem; 1992 Apr; 202(1):188-92. PubMed ID: 1621981
[TBL] [Abstract][Full Text] [Related]
27. Susceptibility to verotoxin as a function of the cell cycle.
Pudymaitis A; Lingwood CA
J Cell Physiol; 1992 Mar; 150(3):632-9. PubMed ID: 1537890
[TBL] [Abstract][Full Text] [Related]
28. Verotoxin induces rapid elimination of human renal tumor xenografts in SCID mice.
Ishitoya S; Kurazono H; Nishiyama H; Nakamura E; Kamoto T; Habuchi T; Terai A; Ogawa O; Yamamoto S
J Urol; 2004 Mar; 171(3):1309-13. PubMed ID: 14767339
[TBL] [Abstract][Full Text] [Related]
29. Conformational changes in cholera toxin B subunit-ganglioside GM1 complexes are elicited by environmental pH and evoke changes in membrane structure.
McCann JA; Mertz JA; Czworkowski J; Picking WD
Biochemistry; 1997 Jul; 36(30):9169-78. PubMed ID: 9230049
[TBL] [Abstract][Full Text] [Related]
30. Effect of globotriaosyl ceramide fatty acid alpha-hydroxylation on the binding by verotoxin 1 and verotoxin 2.
Binnington B; Lingwood D; Nutikka A; Lingwood CA
Neurochem Res; 2002 Aug; 27(7-8):807-13. PubMed ID: 12374217
[TBL] [Abstract][Full Text] [Related]
31. Brefeldin A and filipin distinguish two globotriaosyl ceramide/verotoxin-1 intracellular trafficking pathways involved in Vero cell cytotoxicity.
Khine AA; Tam P; Nutikka A; Lingwood CA
Glycobiology; 2004 Aug; 14(8):701-12. PubMed ID: 15102715
[TBL] [Abstract][Full Text] [Related]
32. Apparent cooperativity in multivalent verotoxin-globotriaosyl ceramide binding: kinetic and saturation binding studies with [(125)I]verotoxin.
Peter MG; Lingwood CA
Biochim Biophys Acta; 2000 Jun; 1501(2-3):116-24. PubMed ID: 10838185
[TBL] [Abstract][Full Text] [Related]
33. Globoside as a membrane receptor: a consideration of oligosaccharide communication with the hydrophobic domain.
Jones DH; Lingwood CA; Barber KR; Grant CW
Biochemistry; 1997 Jul; 36(28):8539-47. PubMed ID: 9214299
[TBL] [Abstract][Full Text] [Related]
34. A mutational analysis of the globotriaosylceramide-binding sites of verotoxin VT1.
Soltyk AM; MacKenzie CR; Wolski VM; Hirama T; Kitov PI; Bundle DR; Brunton JL
J Biol Chem; 2002 Feb; 277(7):5351-9. PubMed ID: 11723119
[TBL] [Abstract][Full Text] [Related]
35. Affinities of Shiga toxins 1 and 2 for univalent and oligovalent Pk-trisaccharide analogs measured by electrospray ionization mass spectrometry.
Kitova EN; Kitov PI; Paszkiewicz E; Kim J; Mulvey GL; Armstrong GD; Bundle DR; Klassen JS
Glycobiology; 2007 Oct; 17(10):1127-37. PubMed ID: 17686801
[TBL] [Abstract][Full Text] [Related]
36. Characterization of protein-glycolipid recognition at the membrane bilayer.
Evans SV; Roger MacKenzie C
J Mol Recognit; 1999; 12(3):155-68. PubMed ID: 10398406
[TBL] [Abstract][Full Text] [Related]
37. Oral therapeutic agents with highly clustered globotriose for treatment of Shiga toxigenic Escherichia coli infections.
Watanabe M; Matsuoka K; Kita E; Igai K; Higashi N; Miyagawa A; Watanabe T; Yanoshita R; Samejima Y; Terunuma D; Natori Y; Nishikawa K
J Infect Dis; 2004 Feb; 189(3):360-8. PubMed ID: 14745692
[TBL] [Abstract][Full Text] [Related]
38. Glycolipid modification of alpha 2 interferon binding. Sequence similarity between the alpha 2 interferon receptor and verotoxin (Shiga-like toxin) B-subunit.
Lingwood CA; Yiu SK
Biochem J; 1992 Apr; 283 ( Pt 1)(Pt 1):25-6. PubMed ID: 1314564
[TBL] [Abstract][Full Text] [Related]
39. Interaction of the Shiga-like toxin type 1 B-subunit with its carbohydrate receptor.
St Hilaire PM; Boyd MK; Toone EJ
Biochemistry; 1994 Dec; 33(48):14452-63. PubMed ID: 7981205
[TBL] [Abstract][Full Text] [Related]
40. Verotoxin 1 from Escherichia coli affects Gb3/CD77+ bovine lymphocytes independent of interleukin-2, tumor necrosis factor-alpha, and interferon-alpha.
Menge C; Stamm I; Blessenohl M; Wieler LH; Baljer G
Exp Biol Med (Maywood); 2003 Apr; 228(4):377-86. PubMed ID: 12671182
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
